nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ESR2—atherosclerosis	0.199	0.619	CbGaD
Tamoxifen—ESR1—atherosclerosis	0.122	0.381	CbGaD
Tamoxifen—ABCB11—Rosuvastatin—atherosclerosis	0.0397	0.0863	CbGbCtD
Tamoxifen—ABCB11—Pravastatin—atherosclerosis	0.0361	0.0785	CbGbCtD
Tamoxifen—ABCC2—Ezetimibe—atherosclerosis	0.0209	0.0454	CbGbCtD
Tamoxifen—ABCC2—Simvastatin—atherosclerosis	0.0194	0.0422	CbGbCtD
Tamoxifen—ABCC2—Pravastatin—atherosclerosis	0.019	0.0413	CbGbCtD
Tamoxifen—ABCC2—Lovastatin—atherosclerosis	0.019	0.0413	CbGbCtD
Tamoxifen—ABCG2—Rosuvastatin—atherosclerosis	0.0189	0.041	CbGbCtD
Tamoxifen—ABCG2—Ezetimibe—atherosclerosis	0.0189	0.041	CbGbCtD
Tamoxifen—ABCG2—Pravastatin—atherosclerosis	0.0172	0.0373	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0129	0.0282	CbGbCtD
Tamoxifen—CYP3A7—Simvastatin—atherosclerosis	0.0129	0.0282	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0127	0.0276	CbGbCtD
Tamoxifen—CYP3A7—Lovastatin—atherosclerosis	0.0127	0.0276	CbGbCtD
Tamoxifen—CYP2B6—Simvastatin—atherosclerosis	0.0123	0.0268	CbGbCtD
Tamoxifen—CYP3A5—Rosuvastatin—atherosclerosis	0.0104	0.0227	CbGbCtD
Tamoxifen—CYP3A5—Simvastatin—atherosclerosis	0.00971	0.0211	CbGbCtD
Tamoxifen—CYP3A5—Pravastatin—atherosclerosis	0.00951	0.0207	CbGbCtD
Tamoxifen—CYP3A5—Lovastatin—atherosclerosis	0.00951	0.0207	CbGbCtD
Tamoxifen—CYP2C8—Simvastatin—atherosclerosis	0.00934	0.0203	CbGbCtD
Tamoxifen—CYP2C8—Pravastatin—atherosclerosis	0.00914	0.0199	CbGbCtD
Tamoxifen—CYP2C8—Lovastatin—atherosclerosis	0.00914	0.0199	CbGbCtD
Tamoxifen—CYP2C19—Rosuvastatin—atherosclerosis	0.00843	0.0183	CbGbCtD
Tamoxifen—CYP2C19—Simvastatin—atherosclerosis	0.00784	0.0171	CbGbCtD
Tamoxifen—CYP2C19—Lovastatin—atherosclerosis	0.00767	0.0167	CbGbCtD
Tamoxifen—CYP2D6—Niacin—atherosclerosis	0.00754	0.0164	CbGbCtD
Tamoxifen—CYP2C9—Rosuvastatin—atherosclerosis	0.00701	0.0152	CbGbCtD
Tamoxifen—ABCB1—Ezetimibe—atherosclerosis	0.0068	0.0148	CbGbCtD
Tamoxifen—CYP2C9—Simvastatin—atherosclerosis	0.00651	0.0142	CbGbCtD
Tamoxifen—CYP2C9—Lovastatin—atherosclerosis	0.00637	0.0139	CbGbCtD
Tamoxifen—CYP2C9—Pravastatin—atherosclerosis	0.00637	0.0139	CbGbCtD
Tamoxifen—ABCB1—Simvastatin—atherosclerosis	0.00632	0.0138	CbGbCtD
Tamoxifen—ABCB1—Lovastatin—atherosclerosis	0.00619	0.0135	CbGbCtD
Tamoxifen—ABCB1—Pravastatin—atherosclerosis	0.00619	0.0135	CbGbCtD
Tamoxifen—CYP2D6—Simvastatin—atherosclerosis	0.00596	0.013	CbGbCtD
Tamoxifen—CYP2D6—Lovastatin—atherosclerosis	0.00583	0.0127	CbGbCtD
Tamoxifen—CYP2D6—Pravastatin—atherosclerosis	0.00583	0.0127	CbGbCtD
Tamoxifen—CYP3A4—Ezetimibe—atherosclerosis	0.00407	0.00887	CbGbCtD
Tamoxifen—CYP3A4—Rosuvastatin—atherosclerosis	0.00407	0.00887	CbGbCtD
Tamoxifen—CYP3A4—Simvastatin—atherosclerosis	0.00379	0.00824	CbGbCtD
Tamoxifen—CYP3A4—Pravastatin—atherosclerosis	0.00371	0.00807	CbGbCtD
Tamoxifen—CYP3A4—Lovastatin—atherosclerosis	0.00371	0.00807	CbGbCtD
Tamoxifen—EBPL—adipose tissue—atherosclerosis	0.000882	0.0511	CbGeAlD
Tamoxifen—SULT1A1—adipose tissue—atherosclerosis	0.000701	0.0406	CbGeAlD
Tamoxifen—EBPL—liver—atherosclerosis	0.000619	0.0359	CbGeAlD
Tamoxifen—EBP—liver—atherosclerosis	0.000593	0.0344	CbGeAlD
Tamoxifen—ESRRA—cardiovascular system—atherosclerosis	0.000557	0.0323	CbGeAlD
Tamoxifen—ESR1—blood vessel—atherosclerosis	0.000513	0.0297	CbGeAlD
Tamoxifen—DHCR7—adipose tissue—atherosclerosis	0.000499	0.0289	CbGeAlD
Tamoxifen—FMO1—adipose tissue—atherosclerosis	0.000499	0.0289	CbGeAlD
Tamoxifen—SULT1A1—liver—atherosclerosis	0.000492	0.0285	CbGeAlD
Tamoxifen—ESRRA—adipose tissue—atherosclerosis	0.000491	0.0284	CbGeAlD
Tamoxifen—CES1—connective tissue—atherosclerosis	0.000443	0.0257	CbGeAlD
Tamoxifen—Clofedanol—HRH1—atherosclerosis	0.000438	0.138	CrCbGaD
Tamoxifen—FMO3—adipose tissue—atherosclerosis	0.000431	0.025	CbGeAlD
Tamoxifen—UGT1A4—liver—atherosclerosis	0.000429	0.0249	CbGeAlD
Tamoxifen—Doxylamine—HRH1—atherosclerosis	0.0004	0.126	CrCbGaD
Tamoxifen—Diethylstilbestrol—ESR2—atherosclerosis	0.000389	0.123	CrCbGaD
Tamoxifen—CES1—cardiovascular system—atherosclerosis	0.000386	0.0224	CbGeAlD
Tamoxifen—ESR2—connective tissue—atherosclerosis	0.000384	0.0222	CbGeAlD
Tamoxifen—Tripelennamine—HRH1—atherosclerosis	0.000381	0.12	CrCbGaD
Tamoxifen—DHCR7—liver—atherosclerosis	0.00035	0.0203	CbGeAlD
Tamoxifen—FMO1—liver—atherosclerosis	0.00035	0.0203	CbGeAlD
Tamoxifen—ESRRA—liver—atherosclerosis	0.000344	0.0199	CbGeAlD
Tamoxifen—CES1—adipose tissue—atherosclerosis	0.00034	0.0197	CbGeAlD
Tamoxifen—ESR2—cardiovascular system—atherosclerosis	0.000334	0.0194	CbGeAlD
Tamoxifen—Bromodiphenhydramine—HRH1—atherosclerosis	0.000313	0.0988	CrCbGaD
Tamoxifen—ABCB11—liver—atherosclerosis	0.000306	0.0177	CbGeAlD
Tamoxifen—CYP19A1—connective tissue—atherosclerosis	0.000303	0.0175	CbGeAlD
Tamoxifen—FMO3—liver—atherosclerosis	0.000302	0.0175	CbGeAlD
Tamoxifen—CYP3A7—liver—atherosclerosis	0.000299	0.0173	CbGeAlD
Tamoxifen—CYP2A6—adipose tissue—atherosclerosis	0.000296	0.0172	CbGeAlD
Tamoxifen—CYP1B1—connective tissue—atherosclerosis	0.000283	0.0164	CbGeAlD
Tamoxifen—Sinusitis—Ezetimibe—atherosclerosis	0.000275	0.00265	CcSEcCtD
Tamoxifen—Hepatitis—Lovastatin—atherosclerosis	0.000268	0.00259	CcSEcCtD
Tamoxifen—Erectile dysfunction—Niacin—atherosclerosis	0.000265	0.00256	CcSEcCtD
Tamoxifen—ESR1—connective tissue—atherosclerosis	0.000263	0.0152	CbGeAlD
Tamoxifen—Hepatitis—Ezetimibe—atherosclerosis	0.000263	0.00254	CcSEcCtD
Tamoxifen—Sinusitis—Simvastatin—atherosclerosis	0.000262	0.00253	CcSEcCtD
Tamoxifen—Pharyngitis—Ezetimibe—atherosclerosis	0.000261	0.00252	CcSEcCtD
Tamoxifen—Erectile dysfunction—Pravastatin—atherosclerosis	0.000261	0.00252	CcSEcCtD
Tamoxifen—Oedema peripheral—Ezetimibe—atherosclerosis	0.000259	0.0025	CcSEcCtD
Tamoxifen—Weight increased—Pravastatin—atherosclerosis	0.000258	0.00249	CcSEcCtD
Tamoxifen—Weight decreased—Pravastatin—atherosclerosis	0.000256	0.00247	CcSEcCtD
Tamoxifen—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000254	0.0147	CbGeAlD
Tamoxifen—Erythema multiforme—Lovastatin—atherosclerosis	0.000253	0.00245	CcSEcCtD
Tamoxifen—Depression—Pravastatin—atherosclerosis	0.000252	0.00243	CcSEcCtD
Tamoxifen—Angioedema—Rosuvastatin—atherosclerosis	0.000252	0.00243	CcSEcCtD
Tamoxifen—Hepatitis—Simvastatin—atherosclerosis	0.000251	0.00242	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00025	0.00242	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000249	0.0024	CcSEcCtD
Tamoxifen—Flushing—Lovastatin—atherosclerosis	0.000249	0.0024	CcSEcCtD
Tamoxifen—Erythema multiforme—Ezetimibe—atherosclerosis	0.000249	0.0024	CcSEcCtD
Tamoxifen—Myocardial infarction—Pravastatin—atherosclerosis	0.000248	0.00239	CcSEcCtD
Tamoxifen—CYP1B1—cardiovascular system—atherosclerosis	0.000246	0.0143	CbGeAlD
Tamoxifen—Sweating—Niacin—atherosclerosis	0.000246	0.00237	CcSEcCtD
Tamoxifen—Urinary tract infection—Pravastatin—atherosclerosis	0.000245	0.00237	CcSEcCtD
Tamoxifen—Flushing—Ezetimibe—atherosclerosis	0.000244	0.00236	CcSEcCtD
Tamoxifen—Cough—Rosuvastatin—atherosclerosis	0.00024	0.00232	CcSEcCtD
Tamoxifen—Diethylstilbestrol—ESR1—atherosclerosis	0.000239	0.0756	CrCbGaD
Tamoxifen—CES1—liver—atherosclerosis	0.000239	0.0138	CbGeAlD
Tamoxifen—Erythema multiforme—Simvastatin—atherosclerosis	0.000237	0.00229	CcSEcCtD
Tamoxifen—Sinusitis—Pravastatin—atherosclerosis	0.000237	0.00229	CcSEcCtD
Tamoxifen—Alopecia—Lovastatin—atherosclerosis	0.000237	0.00229	CcSEcCtD
Tamoxifen—Arthralgia—Rosuvastatin—atherosclerosis	0.000234	0.00226	CcSEcCtD
Tamoxifen—Myalgia—Rosuvastatin—atherosclerosis	0.000234	0.00226	CcSEcCtD
Tamoxifen—Ospemifene—ESR1—atherosclerosis	0.000233	0.0735	CrCbGaD
Tamoxifen—Flushing—Simvastatin—atherosclerosis	0.000233	0.00225	CcSEcCtD
Tamoxifen—Alopecia—Ezetimibe—atherosclerosis	0.000232	0.00224	CcSEcCtD
Tamoxifen—CYP19A1—adipose tissue—atherosclerosis	0.000232	0.0135	CbGeAlD
Tamoxifen—Haemoglobin—Niacin—atherosclerosis	0.000231	0.00223	CcSEcCtD
Tamoxifen—Haemorrhage—Niacin—atherosclerosis	0.00023	0.00222	CcSEcCtD
Tamoxifen—Hepatitis—Niacin—atherosclerosis	0.00023	0.00222	CcSEcCtD
Tamoxifen—Hypoaesthesia—Niacin—atherosclerosis	0.000229	0.00221	CcSEcCtD
Tamoxifen—Erythema—Ezetimibe—atherosclerosis	0.000229	0.00221	CcSEcCtD
Tamoxifen—ESR1—cardiovascular system—atherosclerosis	0.000229	0.0133	CbGeAlD
Tamoxifen—Dysgeusia—Lovastatin—atherosclerosis	0.000229	0.00221	CcSEcCtD
Tamoxifen—SIGMAR1—adipose tissue—atherosclerosis	0.000228	0.0132	CbGeAlD
Tamoxifen—Oedema peripheral—Niacin—atherosclerosis	0.000227	0.00219	CcSEcCtD
Tamoxifen—Hepatitis—Pravastatin—atherosclerosis	0.000227	0.00219	CcSEcCtD
Tamoxifen—Back pain—Lovastatin—atherosclerosis	0.000226	0.00218	CcSEcCtD
Tamoxifen—Hypoaesthesia—Pravastatin—atherosclerosis	0.000226	0.00218	CcSEcCtD
Tamoxifen—Pharyngitis—Pravastatin—atherosclerosis	0.000225	0.00217	CcSEcCtD
Tamoxifen—Muscle spasms—Lovastatin—atherosclerosis	0.000224	0.00217	CcSEcCtD
Tamoxifen—Infection—Rosuvastatin—atherosclerosis	0.000223	0.00216	CcSEcCtD
Tamoxifen—Visual impairment—Niacin—atherosclerosis	0.000222	0.00214	CcSEcCtD
Tamoxifen—Alopecia—Simvastatin—atherosclerosis	0.000222	0.00214	CcSEcCtD
Tamoxifen—Back pain—Ezetimibe—atherosclerosis	0.000221	0.00214	CcSEcCtD
Tamoxifen—Muscle spasms—Ezetimibe—atherosclerosis	0.00022	0.00213	CcSEcCtD
Tamoxifen—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00022	0.00212	CcSEcCtD
Tamoxifen—Visual impairment—Pravastatin—atherosclerosis	0.000218	0.00211	CcSEcCtD
Tamoxifen—Erythema—Simvastatin—atherosclerosis	0.000218	0.00211	CcSEcCtD
Tamoxifen—CYP1B1—adipose tissue—atherosclerosis	0.000217	0.0126	CbGeAlD
Tamoxifen—Erythema multiforme—Pravastatin—atherosclerosis	0.000214	0.00207	CcSEcCtD
Tamoxifen—Dysgeusia—Simvastatin—atherosclerosis	0.000214	0.00206	CcSEcCtD
Tamoxifen—Flushing—Niacin—atherosclerosis	0.000214	0.00206	CcSEcCtD
Tamoxifen—Angioedema—Lovastatin—atherosclerosis	0.000213	0.00206	CcSEcCtD
Tamoxifen—Anaemia—Ezetimibe—atherosclerosis	0.000212	0.00204	CcSEcCtD
Tamoxifen—Flushing—Pravastatin—atherosclerosis	0.00021	0.00203	CcSEcCtD
Tamoxifen—Muscle spasms—Simvastatin—atherosclerosis	0.00021	0.00203	CcSEcCtD
Tamoxifen—Angioedema—Ezetimibe—atherosclerosis	0.000209	0.00202	CcSEcCtD
Tamoxifen—Leukopenia—Lovastatin—atherosclerosis	0.000209	0.00202	CcSEcCtD
Tamoxifen—CYP2A6—liver—atherosclerosis	0.000208	0.012	CbGeAlD
Tamoxifen—ESR2—liver—atherosclerosis	0.000207	0.012	CbGeAlD
Tamoxifen—Arrhythmia—Niacin—atherosclerosis	0.000206	0.00199	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000205	0.00198	CcSEcCtD
Tamoxifen—Alopecia—Niacin—atherosclerosis	0.000203	0.00196	CcSEcCtD
Tamoxifen—Insomnia—Rosuvastatin—atherosclerosis	0.000203	0.00196	CcSEcCtD
Tamoxifen—ABCB1—blood vessel—atherosclerosis	0.000203	0.0117	CbGeAlD
Tamoxifen—Arrhythmia—Pravastatin—atherosclerosis	0.000203	0.00196	CcSEcCtD
Tamoxifen—Paraesthesia—Rosuvastatin—atherosclerosis	0.000202	0.00195	CcSEcCtD
Tamoxifen—Anaemia—Simvastatin—atherosclerosis	0.000202	0.00195	CcSEcCtD
Tamoxifen—ESR1—adipose tissue—atherosclerosis	0.000202	0.0117	CbGeAlD
Tamoxifen—Erythema—Niacin—atherosclerosis	0.0002	0.00194	CcSEcCtD
Tamoxifen—Alopecia—Pravastatin—atherosclerosis	0.0002	0.00193	CcSEcCtD
Tamoxifen—Cough—Ezetimibe—atherosclerosis	0.0002	0.00193	CcSEcCtD
Tamoxifen—Angioedema—Simvastatin—atherosclerosis	0.000199	0.00193	CcSEcCtD
Tamoxifen—Myalgia—Lovastatin—atherosclerosis	0.000199	0.00192	CcSEcCtD
Tamoxifen—Chest pain—Lovastatin—atherosclerosis	0.000199	0.00192	CcSEcCtD
Tamoxifen—Arthralgia—Lovastatin—atherosclerosis	0.000199	0.00192	CcSEcCtD
Tamoxifen—Anxiety—Lovastatin—atherosclerosis	0.000198	0.00191	CcSEcCtD
Tamoxifen—Dyspepsia—Rosuvastatin—atherosclerosis	0.000198	0.00191	CcSEcCtD
Tamoxifen—Hypertension—Ezetimibe—atherosclerosis	0.000198	0.00191	CcSEcCtD
Tamoxifen—Discomfort—Lovastatin—atherosclerosis	0.000196	0.0019	CcSEcCtD
Tamoxifen—Leukopenia—Simvastatin—atherosclerosis	0.000195	0.00189	CcSEcCtD
Tamoxifen—Arthralgia—Ezetimibe—atherosclerosis	0.000195	0.00188	CcSEcCtD
Tamoxifen—Chest pain—Ezetimibe—atherosclerosis	0.000195	0.00188	CcSEcCtD
Tamoxifen—Myalgia—Ezetimibe—atherosclerosis	0.000195	0.00188	CcSEcCtD
Tamoxifen—Dry mouth—Lovastatin—atherosclerosis	0.000194	0.00188	CcSEcCtD
Tamoxifen—Dysgeusia—Pravastatin—atherosclerosis	0.000193	0.00187	CcSEcCtD
Tamoxifen—Muscle spasms—Niacin—atherosclerosis	0.000193	0.00186	CcSEcCtD
Tamoxifen—Discomfort—Ezetimibe—atherosclerosis	0.000193	0.00186	CcSEcCtD
Tamoxifen—Pain—Rosuvastatin—atherosclerosis	0.000192	0.00186	CcSEcCtD
Tamoxifen—Constipation—Rosuvastatin—atherosclerosis	0.000192	0.00186	CcSEcCtD
Tamoxifen—Dry mouth—Ezetimibe—atherosclerosis	0.000191	0.00184	CcSEcCtD
Tamoxifen—Toremifene—ESR1—atherosclerosis	0.00019	0.0599	CrCbGaD
Tamoxifen—Muscle spasms—Pravastatin—atherosclerosis	0.00019	0.00183	CcSEcCtD
Tamoxifen—Infection—Lovastatin—atherosclerosis	0.000189	0.00183	CcSEcCtD
Tamoxifen—Thrombocytopenia—Lovastatin—atherosclerosis	0.000186	0.0018	CcSEcCtD
Tamoxifen—Myalgia—Simvastatin—atherosclerosis	0.000186	0.00179	CcSEcCtD
Tamoxifen—Chest pain—Simvastatin—atherosclerosis	0.000186	0.00179	CcSEcCtD
Tamoxifen—Arthralgia—Simvastatin—atherosclerosis	0.000186	0.00179	CcSEcCtD
Tamoxifen—Infection—Ezetimibe—atherosclerosis	0.000186	0.00179	CcSEcCtD
Tamoxifen—Anxiety—Simvastatin—atherosclerosis	0.000185	0.00179	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000184	0.00177	CcSEcCtD
Tamoxifen—Discomfort—Simvastatin—atherosclerosis	0.000184	0.00177	CcSEcCtD
Tamoxifen—Angioedema—Niacin—atherosclerosis	0.000183	0.00177	CcSEcCtD
Tamoxifen—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000183	0.00177	CcSEcCtD
Tamoxifen—Anaemia—Pravastatin—atherosclerosis	0.000182	0.00176	CcSEcCtD
Tamoxifen—Anorexia—Lovastatin—atherosclerosis	0.000182	0.00175	CcSEcCtD
Tamoxifen—Angioedema—Pravastatin—atherosclerosis	0.00018	0.00174	CcSEcCtD
Tamoxifen—Leukopenia—Niacin—atherosclerosis	0.000179	0.00173	CcSEcCtD
Tamoxifen—Urticaria—Rosuvastatin—atherosclerosis	0.000179	0.00172	CcSEcCtD
Tamoxifen—Oedema—Simvastatin—atherosclerosis	0.000178	0.00172	CcSEcCtD
Tamoxifen—Abdominal pain—Rosuvastatin—atherosclerosis	0.000178	0.00172	CcSEcCtD
Tamoxifen—Infection—Simvastatin—atherosclerosis	0.000177	0.00171	CcSEcCtD
Tamoxifen—Leukopenia—Pravastatin—atherosclerosis	0.000177	0.00171	CcSEcCtD
Tamoxifen—Cough—Niacin—atherosclerosis	0.000175	0.00169	CcSEcCtD
Tamoxifen—Thrombocytopenia—Simvastatin—atherosclerosis	0.000174	0.00168	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000174	0.00168	CcSEcCtD
Tamoxifen—Insomnia—Lovastatin—atherosclerosis	0.000172	0.00166	CcSEcCtD
Tamoxifen—Cough—Pravastatin—atherosclerosis	0.000172	0.00166	CcSEcCtD
Tamoxifen—Paraesthesia—Lovastatin—atherosclerosis	0.000171	0.00165	CcSEcCtD
Tamoxifen—Arthralgia—Niacin—atherosclerosis	0.000171	0.00165	CcSEcCtD
Tamoxifen—Myalgia—Niacin—atherosclerosis	0.000171	0.00165	CcSEcCtD
Tamoxifen—Hypertension—Pravastatin—atherosclerosis	0.00017	0.00165	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00017	0.00164	CcSEcCtD
Tamoxifen—Anorexia—Simvastatin—atherosclerosis	0.00017	0.00164	CcSEcCtD
Tamoxifen—Dyspnoea—Lovastatin—atherosclerosis	0.00017	0.00164	CcSEcCtD
Tamoxifen—CYP2B6—cardiovascular system—atherosclerosis	0.000169	0.0098	CbGeAlD
Tamoxifen—Insomnia—Ezetimibe—atherosclerosis	0.000169	0.00163	CcSEcCtD
Tamoxifen—Arthralgia—Pravastatin—atherosclerosis	0.000168	0.00162	CcSEcCtD
Tamoxifen—Myalgia—Pravastatin—atherosclerosis	0.000168	0.00162	CcSEcCtD
Tamoxifen—Chest pain—Pravastatin—atherosclerosis	0.000168	0.00162	CcSEcCtD
Tamoxifen—Paraesthesia—Ezetimibe—atherosclerosis	0.000168	0.00162	CcSEcCtD
Tamoxifen—Dyspepsia—Lovastatin—atherosclerosis	0.000168	0.00162	CcSEcCtD
Tamoxifen—Anxiety—Pravastatin—atherosclerosis	0.000167	0.00162	CcSEcCtD
Tamoxifen—CYP2C9—cardiovascular system—atherosclerosis	0.000167	0.0097	CbGeAlD
Tamoxifen—Dry mouth—Niacin—atherosclerosis	0.000167	0.00161	CcSEcCtD
Tamoxifen—Dyspnoea—Ezetimibe—atherosclerosis	0.000167	0.00161	CcSEcCtD
Tamoxifen—Discomfort—Pravastatin—atherosclerosis	0.000166	0.0016	CcSEcCtD
Tamoxifen—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000166	0.0016	CcSEcCtD
Tamoxifen—Decreased appetite—Lovastatin—atherosclerosis	0.000166	0.0016	CcSEcCtD
Tamoxifen—Dyspepsia—Ezetimibe—atherosclerosis	0.000164	0.00159	CcSEcCtD
Tamoxifen—Fatigue—Lovastatin—atherosclerosis	0.000164	0.00159	CcSEcCtD
Tamoxifen—Clomifene—ESR1—atherosclerosis	0.000164	0.0518	CrCbGaD
Tamoxifen—Oedema—Niacin—atherosclerosis	0.000164	0.00158	CcSEcCtD
Tamoxifen—Pain—Lovastatin—atherosclerosis	0.000163	0.00157	CcSEcCtD
Tamoxifen—Constipation—Lovastatin—atherosclerosis	0.000163	0.00157	CcSEcCtD
Tamoxifen—CYP19A1—liver—atherosclerosis	0.000163	0.00943	CbGeAlD
Tamoxifen—Decreased appetite—Ezetimibe—atherosclerosis	0.000162	0.00157	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000162	0.00157	CcSEcCtD
Tamoxifen—ABCG2—adipose tissue—atherosclerosis	0.000162	0.00936	CbGeAlD
Tamoxifen—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000161	0.00156	CcSEcCtD
Tamoxifen—Asthenia—Rosuvastatin—atherosclerosis	0.000161	0.00156	CcSEcCtD
Tamoxifen—Insomnia—Simvastatin—atherosclerosis	0.000161	0.00156	CcSEcCtD
Tamoxifen—Oedema—Pravastatin—atherosclerosis	0.000161	0.00156	CcSEcCtD
Tamoxifen—Fatigue—Ezetimibe—atherosclerosis	0.000161	0.00156	CcSEcCtD
Tamoxifen—SIGMAR1—liver—atherosclerosis	0.00016	0.00928	CbGeAlD
Tamoxifen—Infection—Pravastatin—atherosclerosis	0.00016	0.00155	CcSEcCtD
Tamoxifen—Paraesthesia—Simvastatin—atherosclerosis	0.00016	0.00154	CcSEcCtD
Tamoxifen—Pain—Ezetimibe—atherosclerosis	0.00016	0.00154	CcSEcCtD
Tamoxifen—Constipation—Ezetimibe—atherosclerosis	0.00016	0.00154	CcSEcCtD
Tamoxifen—Pruritus—Rosuvastatin—atherosclerosis	0.000159	0.00154	CcSEcCtD
Tamoxifen—Dyspnoea—Simvastatin—atherosclerosis	0.000159	0.00153	CcSEcCtD
Tamoxifen—CYP2E1—cardiovascular system—atherosclerosis	0.000159	0.00919	CbGeAlD
Tamoxifen—Hyperhidrosis—Niacin—atherosclerosis	0.000158	0.00153	CcSEcCtD
Tamoxifen—Thrombocytopenia—Pravastatin—atherosclerosis	0.000158	0.00152	CcSEcCtD
Tamoxifen—Dyspepsia—Simvastatin—atherosclerosis	0.000157	0.00151	CcSEcCtD
Tamoxifen—Anorexia—Niacin—atherosclerosis	0.000156	0.00151	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000156	0.0015	CcSEcCtD
Tamoxifen—Hyperhidrosis—Pravastatin—atherosclerosis	0.000156	0.0015	CcSEcCtD
Tamoxifen—ABCC2—liver—atherosclerosis	0.000155	0.00901	CbGeAlD
Tamoxifen—Decreased appetite—Simvastatin—atherosclerosis	0.000155	0.0015	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000154	0.00149	CcSEcCtD
Tamoxifen—Diarrhoea—Rosuvastatin—atherosclerosis	0.000154	0.00148	CcSEcCtD
Tamoxifen—Fatigue—Simvastatin—atherosclerosis	0.000154	0.00148	CcSEcCtD
Tamoxifen—Anorexia—Pravastatin—atherosclerosis	0.000154	0.00148	CcSEcCtD
Tamoxifen—CYP1A1—adipose tissue—atherosclerosis	0.000153	0.00889	CbGeAlD
Tamoxifen—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000153	0.00148	CcSEcCtD
Tamoxifen—Constipation—Simvastatin—atherosclerosis	0.000152	0.00147	CcSEcCtD
Tamoxifen—Pain—Simvastatin—atherosclerosis	0.000152	0.00147	CcSEcCtD
Tamoxifen—CYP1B1—liver—atherosclerosis	0.000152	0.00882	CbGeAlD
Tamoxifen—Urticaria—Lovastatin—atherosclerosis	0.000151	0.00146	CcSEcCtD
Tamoxifen—Abdominal pain—Lovastatin—atherosclerosis	0.000151	0.00145	CcSEcCtD
Tamoxifen—Diphenhydramine—HRH1—atherosclerosis	0.00015	0.0474	CrCbGaD
Tamoxifen—CYP3A5—adipose tissue—atherosclerosis	0.00015	0.00869	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000149	0.00144	CcSEcCtD
Tamoxifen—Dizziness—Rosuvastatin—atherosclerosis	0.000149	0.00144	CcSEcCtD
Tamoxifen—Urticaria—Ezetimibe—atherosclerosis	0.000148	0.00143	CcSEcCtD
Tamoxifen—Insomnia—Niacin—atherosclerosis	0.000148	0.00143	CcSEcCtD
Tamoxifen—Abdominal pain—Ezetimibe—atherosclerosis	0.000148	0.00143	CcSEcCtD
Tamoxifen—Paraesthesia—Niacin—atherosclerosis	0.000147	0.00142	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000147	0.00142	CcSEcCtD
Tamoxifen—Dyspnoea—Niacin—atherosclerosis	0.000146	0.00141	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000146	0.00141	CcSEcCtD
Tamoxifen—Insomnia—Pravastatin—atherosclerosis	0.000146	0.00141	CcSEcCtD
Tamoxifen—Paraesthesia—Pravastatin—atherosclerosis	0.000145	0.0014	CcSEcCtD
Tamoxifen—Dyspepsia—Niacin—atherosclerosis	0.000144	0.00139	CcSEcCtD
Tamoxifen—Dyspnoea—Pravastatin—atherosclerosis	0.000144	0.00139	CcSEcCtD
Tamoxifen—Decreased appetite—Niacin—atherosclerosis	0.000142	0.00137	CcSEcCtD
Tamoxifen—Orphenadrine—HRH1—atherosclerosis	0.000142	0.0448	CrCbGaD
Tamoxifen—Dyspepsia—Pravastatin—atherosclerosis	0.000142	0.00137	CcSEcCtD
Tamoxifen—Rash—Rosuvastatin—atherosclerosis	0.000142	0.00137	CcSEcCtD
Tamoxifen—Dermatitis—Rosuvastatin—atherosclerosis	0.000142	0.00137	CcSEcCtD
Tamoxifen—Urticaria—Simvastatin—atherosclerosis	0.000142	0.00137	CcSEcCtD
Tamoxifen—ESR1—liver—atherosclerosis	0.000141	0.0082	CbGeAlD
Tamoxifen—Gastrointestinal disorder—Niacin—atherosclerosis	0.000141	0.00136	CcSEcCtD
Tamoxifen—Abdominal pain—Simvastatin—atherosclerosis	0.000141	0.00136	CcSEcCtD
Tamoxifen—Headache—Rosuvastatin—atherosclerosis	0.000141	0.00136	CcSEcCtD
Tamoxifen—Hypersensitivity—Lovastatin—atherosclerosis	0.00014	0.00136	CcSEcCtD
Tamoxifen—Decreased appetite—Pravastatin—atherosclerosis	0.00014	0.00135	CcSEcCtD
Tamoxifen—Pain—Niacin—atherosclerosis	0.00014	0.00135	CcSEcCtD
Tamoxifen—Fatigue—Pravastatin—atherosclerosis	0.000139	0.00134	CcSEcCtD
Tamoxifen—Pain—Pravastatin—atherosclerosis	0.000138	0.00133	CcSEcCtD
Tamoxifen—Constipation—Pravastatin—atherosclerosis	0.000138	0.00133	CcSEcCtD
Tamoxifen—Hypersensitivity—Ezetimibe—atherosclerosis	0.000138	0.00133	CcSEcCtD
Tamoxifen—Asthenia—Lovastatin—atherosclerosis	0.000137	0.00132	CcSEcCtD
Tamoxifen—Pruritus—Lovastatin—atherosclerosis	0.000135	0.0013	CcSEcCtD
Tamoxifen—Asthenia—Ezetimibe—atherosclerosis	0.000134	0.00129	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Niacin—atherosclerosis	0.000134	0.00129	CcSEcCtD
Tamoxifen—CYP2C19—liver—atherosclerosis	0.000134	0.00774	CbGeAlD
Tamoxifen—Nausea—Rosuvastatin—atherosclerosis	0.000133	0.00129	CcSEcCtD
Tamoxifen—Pruritus—Ezetimibe—atherosclerosis	0.000132	0.00128	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000132	0.00127	CcSEcCtD
Tamoxifen—Hypersensitivity—Simvastatin—atherosclerosis	0.000131	0.00127	CcSEcCtD
Tamoxifen—Diarrhoea—Lovastatin—atherosclerosis	0.00013	0.00126	CcSEcCtD
Tamoxifen—Urticaria—Niacin—atherosclerosis	0.00013	0.00125	CcSEcCtD
Tamoxifen—Promazine—HRH1—atherosclerosis	0.00013	0.0409	CrCbGaD
Tamoxifen—Abdominal pain—Niacin—atherosclerosis	0.000129	0.00125	CcSEcCtD
Tamoxifen—Urticaria—Pravastatin—atherosclerosis	0.000128	0.00124	CcSEcCtD
Tamoxifen—Asthenia—Simvastatin—atherosclerosis	0.000128	0.00123	CcSEcCtD
Tamoxifen—Diarrhoea—Ezetimibe—atherosclerosis	0.000128	0.00123	CcSEcCtD
Tamoxifen—Abdominal pain—Pravastatin—atherosclerosis	0.000127	0.00123	CcSEcCtD
Tamoxifen—Pruritus—Simvastatin—atherosclerosis	0.000126	0.00122	CcSEcCtD
Tamoxifen—Dizziness—Lovastatin—atherosclerosis	0.000126	0.00122	CcSEcCtD
Tamoxifen—Dizziness—Ezetimibe—atherosclerosis	0.000124	0.00119	CcSEcCtD
Tamoxifen—Diarrhoea—Simvastatin—atherosclerosis	0.000122	0.00118	CcSEcCtD
Tamoxifen—Vomiting—Lovastatin—atherosclerosis	0.000121	0.00117	CcSEcCtD
Tamoxifen—Hypersensitivity—Niacin—atherosclerosis	0.000121	0.00116	CcSEcCtD
Tamoxifen—Rash—Lovastatin—atherosclerosis	0.00012	0.00116	CcSEcCtD
Tamoxifen—Dermatitis—Lovastatin—atherosclerosis	0.00012	0.00116	CcSEcCtD
Tamoxifen—Headache—Lovastatin—atherosclerosis	0.000119	0.00115	CcSEcCtD
Tamoxifen—Vomiting—Ezetimibe—atherosclerosis	0.000119	0.00115	CcSEcCtD
Tamoxifen—Hypersensitivity—Pravastatin—atherosclerosis	0.000119	0.00115	CcSEcCtD
Tamoxifen—Dizziness—Simvastatin—atherosclerosis	0.000118	0.00114	CcSEcCtD
Tamoxifen—Rash—Ezetimibe—atherosclerosis	0.000118	0.00114	CcSEcCtD
Tamoxifen—Dermatitis—Ezetimibe—atherosclerosis	0.000118	0.00114	CcSEcCtD
Tamoxifen—Asthenia—Niacin—atherosclerosis	0.000117	0.00113	CcSEcCtD
Tamoxifen—Headache—Ezetimibe—atherosclerosis	0.000117	0.00113	CcSEcCtD
Tamoxifen—CYP2C8—liver—atherosclerosis	0.000117	0.00675	CbGeAlD
Tamoxifen—Pruritus—Niacin—atherosclerosis	0.000116	0.00112	CcSEcCtD
Tamoxifen—Asthenia—Pravastatin—atherosclerosis	0.000116	0.00112	CcSEcCtD
Tamoxifen—Pruritus—Pravastatin—atherosclerosis	0.000114	0.0011	CcSEcCtD
Tamoxifen—ABCG2—liver—atherosclerosis	0.000113	0.00657	CbGeAlD
Tamoxifen—Vomiting—Simvastatin—atherosclerosis	0.000113	0.00109	CcSEcCtD
Tamoxifen—Nausea—Lovastatin—atherosclerosis	0.000113	0.00109	CcSEcCtD
Tamoxifen—Rash—Simvastatin—atherosclerosis	0.000112	0.00108	CcSEcCtD
Tamoxifen—Dermatitis—Simvastatin—atherosclerosis	0.000112	0.00108	CcSEcCtD
Tamoxifen—Diarrhoea—Niacin—atherosclerosis	0.000112	0.00108	CcSEcCtD
Tamoxifen—Headache—Simvastatin—atherosclerosis	0.000112	0.00108	CcSEcCtD
Tamoxifen—Nausea—Ezetimibe—atherosclerosis	0.000111	0.00107	CcSEcCtD
Tamoxifen—Diarrhoea—Pravastatin—atherosclerosis	0.00011	0.00106	CcSEcCtD
Tamoxifen—CYP1A2—liver—atherosclerosis	0.000109	0.00632	CbGeAlD
Tamoxifen—Dizziness—Niacin—atherosclerosis	0.000108	0.00104	CcSEcCtD
Tamoxifen—CYP1A1—liver—atherosclerosis	0.000108	0.00623	CbGeAlD
Tamoxifen—Dizziness—Pravastatin—atherosclerosis	0.000107	0.00103	CcSEcCtD
Tamoxifen—Nausea—Simvastatin—atherosclerosis	0.000106	0.00102	CcSEcCtD
Tamoxifen—CYP3A5—liver—atherosclerosis	0.000105	0.0061	CbGeAlD
Tamoxifen—CYP2B6—liver—atherosclerosis	0.000105	0.00606	CbGeAlD
Tamoxifen—Vomiting—Niacin—atherosclerosis	0.000104	0.001	CcSEcCtD
Tamoxifen—CYP2C9—liver—atherosclerosis	0.000104	0.006	CbGeAlD
Tamoxifen—Rash—Niacin—atherosclerosis	0.000103	0.000996	CcSEcCtD
Tamoxifen—Dermatitis—Niacin—atherosclerosis	0.000103	0.000995	CcSEcCtD
Tamoxifen—Headache—Niacin—atherosclerosis	0.000102	0.00099	CcSEcCtD
Tamoxifen—Vomiting—Pravastatin—atherosclerosis	0.000102	0.000989	CcSEcCtD
Tamoxifen—Rash—Pravastatin—atherosclerosis	0.000102	0.000981	CcSEcCtD
Tamoxifen—Dermatitis—Pravastatin—atherosclerosis	0.000101	0.00098	CcSEcCtD
Tamoxifen—Headache—Pravastatin—atherosclerosis	0.000101	0.000974	CcSEcCtD
Tamoxifen—CYP2E1—liver—atherosclerosis	9.81e-05	0.00569	CbGeAlD
Tamoxifen—Nausea—Niacin—atherosclerosis	9.72e-05	0.000938	CcSEcCtD
Tamoxifen—Nausea—Pravastatin—atherosclerosis	9.57e-05	0.000924	CcSEcCtD
Tamoxifen—ABCB1—cardiovascular system—atherosclerosis	9.04e-05	0.00524	CbGeAlD
Tamoxifen—ABCB1—adipose tissue—atherosclerosis	7.97e-05	0.00462	CbGeAlD
Tamoxifen—CYP3A4—liver—atherosclerosis	7.89e-05	0.00458	CbGeAlD
Tamoxifen—CYP2D6—liver—atherosclerosis	7.77e-05	0.0045	CbGeAlD
Tamoxifen—ABCB1—liver—atherosclerosis	5.59e-05	0.00324	CbGeAlD
Tamoxifen—CYP1A2—Metabolism—CETP—atherosclerosis	2.41e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CD36—atherosclerosis	2.41e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CD36—atherosclerosis	2.4e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HMOX1—atherosclerosis	2.39e-06	2.51e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—LPL—atherosclerosis	2.39e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—F2—atherosclerosis	2.38e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BGN—atherosclerosis	2.35e-06	2.46e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PPARG—atherosclerosis	2.34e-06	2.45e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GPX1—atherosclerosis	2.33e-06	2.44e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MTHFR—atherosclerosis	2.33e-06	2.44e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOA5—atherosclerosis	2.32e-06	2.44e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ALB—atherosclerosis	2.32e-06	2.43e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—atherosclerosis	2.31e-06	2.43e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SCARB1—atherosclerosis	2.31e-06	2.42e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.3e-06	2.41e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ALB—atherosclerosis	2.3e-06	2.41e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—INS—atherosclerosis	2.3e-06	2.41e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOB—atherosclerosis	2.29e-06	2.4e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.29e-06	2.4e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARA—atherosclerosis	2.28e-06	2.4e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MTHFR—atherosclerosis	2.28e-06	2.39e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	2.28e-06	2.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MTHFR—atherosclerosis	2.28e-06	2.39e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.27e-06	2.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CD36—atherosclerosis	2.27e-06	2.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.24e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARA—atherosclerosis	2.24e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.24e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARA—atherosclerosis	2.23e-06	2.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTM1—atherosclerosis	2.23e-06	2.34e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—atherosclerosis	2.23e-06	2.34e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—NOS3—atherosclerosis	2.22e-06	2.32e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AGT—atherosclerosis	2.21e-06	2.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—NOS3—atherosclerosis	2.2e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—LPL—atherosclerosis	2.19e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMGCR—atherosclerosis	2.18e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOE—atherosclerosis	2.17e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AGT—atherosclerosis	2.17e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AGT—atherosclerosis	2.16e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.16e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—INS—atherosclerosis	2.16e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MTHFR—atherosclerosis	2.15e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CAV1—atherosclerosis	2.15e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOA1—atherosclerosis	2.14e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HMOX1—atherosclerosis	2.14e-06	2.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GPX1—atherosclerosis	2.14e-06	2.24e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL2—atherosclerosis	2.12e-06	2.23e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—atherosclerosis	2.12e-06	2.23e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—atherosclerosis	2.12e-06	2.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARA—atherosclerosis	2.11e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—atherosclerosis	2.1e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CAV1—atherosclerosis	2.1e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CAV1—atherosclerosis	2.1e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOA1—atherosclerosis	2.1e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOA1—atherosclerosis	2.09e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—atherosclerosis	2.09e-06	2.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1—atherosclerosis	2.09e-06	2.19e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HMOX1—atherosclerosis	2.09e-06	2.19e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CD36—atherosclerosis	2.08e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOB—atherosclerosis	2.05e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AGT—atherosclerosis	2.04e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—atherosclerosis	2.03e-06	2.12e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NOS3—atherosclerosis	2.01e-06	2.11e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—atherosclerosis	2.01e-06	2.11e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—atherosclerosis	2e-06	2.1e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOB—atherosclerosis	2e-06	2.09e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.99e-06	2.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MAPK3—atherosclerosis	1.98e-06	2.08e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CAV1—atherosclerosis	1.98e-06	2.08e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	1.98e-06	2.08e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOA1—atherosclerosis	1.98e-06	2.08e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—atherosclerosis	1.97e-06	2.07e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.97e-06	2.06e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.96e-06	2.06e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—atherosclerosis	1.96e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—LPL—atherosclerosis	1.95e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.95e-06	2.04e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—atherosclerosis	1.94e-06	2.04e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.94e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.94e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARA—atherosclerosis	1.93e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LIPC—atherosclerosis	1.93e-06	2.02e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.92e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOC3—atherosclerosis	1.91e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—atherosclerosis	1.91e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—LPL—atherosclerosis	1.91e-06	2e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GPX1—atherosclerosis	1.91e-06	2e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LDLR—atherosclerosis	1.9e-06	1.99e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOS3—atherosclerosis	1.89e-06	1.99e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—atherosclerosis	1.89e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOB—atherosclerosis	1.88e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AGT—atherosclerosis	1.87e-06	1.96e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOB—atherosclerosis	1.87e-06	1.96e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GPX1—atherosclerosis	1.86e-06	1.95e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CETP—atherosclerosis	1.86e-06	1.95e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CD36—atherosclerosis	1.86e-06	1.95e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—INS—atherosclerosis	1.85e-06	1.94e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—atherosclerosis	1.85e-06	1.94e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—atherosclerosis	1.85e-06	1.94e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—atherosclerosis	1.84e-06	1.93e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—atherosclerosis	1.84e-06	1.92e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.83e-06	1.92e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CAV1—atherosclerosis	1.82e-06	1.91e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.82e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOA1—atherosclerosis	1.81e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—INS—atherosclerosis	1.81e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CD36—atherosclerosis	1.81e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—INS—atherosclerosis	1.81e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—atherosclerosis	1.81e-06	1.89e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—LPL—atherosclerosis	1.8e-06	1.88e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—LPL—atherosclerosis	1.78e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.78e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.76e-06	1.85e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GPX1—atherosclerosis	1.75e-06	1.84e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—atherosclerosis	1.74e-06	1.83e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GPX1—atherosclerosis	1.74e-06	1.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARA—atherosclerosis	1.73e-06	1.81e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—atherosclerosis	1.72e-06	1.8e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—INS—atherosclerosis	1.71e-06	1.79e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CD36—atherosclerosis	1.71e-06	1.79e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—atherosclerosis	1.7e-06	1.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CD36—atherosclerosis	1.69e-06	1.78e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARA—atherosclerosis	1.68e-06	1.77e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.68e-06	1.76e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—atherosclerosis	1.68e-06	1.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AGT—atherosclerosis	1.67e-06	1.75e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.66e-06	1.75e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—atherosclerosis	1.66e-06	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—atherosclerosis	1.66e-06	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—atherosclerosis	1.66e-06	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—atherosclerosis	1.64e-06	1.72e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AGT—atherosclerosis	1.63e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NOS3—atherosclerosis	1.62e-06	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAV1—atherosclerosis	1.62e-06	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOA1—atherosclerosis	1.62e-06	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.62e-06	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.6e-06	1.68e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—atherosclerosis	1.6e-06	1.68e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—atherosclerosis	1.6e-06	1.68e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOB—atherosclerosis	1.59e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NOS3—atherosclerosis	1.59e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARA—atherosclerosis	1.59e-06	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NOS3—atherosclerosis	1.59e-06	1.66e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAV1—atherosclerosis	1.58e-06	1.66e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOA1—atherosclerosis	1.58e-06	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARA—atherosclerosis	1.57e-06	1.65e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—INS—atherosclerosis	1.57e-06	1.64e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—atherosclerosis	1.57e-06	1.64e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.55e-06	1.63e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—atherosclerosis	1.54e-06	1.62e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AGT—atherosclerosis	1.54e-06	1.61e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AGT—atherosclerosis	1.52e-06	1.6e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—LPL—atherosclerosis	1.52e-06	1.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—atherosclerosis	1.52e-06	1.59e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—atherosclerosis	1.51e-06	1.58e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NFKB1—atherosclerosis	1.5e-06	1.58e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NOS3—atherosclerosis	1.5e-06	1.57e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.5e-06	1.57e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—atherosclerosis	1.49e-06	1.57e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAV1—atherosclerosis	1.49e-06	1.57e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOA1—atherosclerosis	1.49e-06	1.56e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GPX1—atherosclerosis	1.49e-06	1.56e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—atherosclerosis	1.49e-06	1.56e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAV1—atherosclerosis	1.48e-06	1.55e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.48e-06	1.55e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK8—atherosclerosis	1.48e-06	1.55e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOA1—atherosclerosis	1.48e-06	1.55e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.45e-06	1.53e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—atherosclerosis	1.45e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CD36—atherosclerosis	1.45e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.44e-06	1.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—atherosclerosis	1.44e-06	1.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—atherosclerosis	1.43e-06	1.5e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—INS—atherosclerosis	1.4e-06	1.47e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—atherosclerosis	1.39e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NOS3—atherosclerosis	1.37e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—atherosclerosis	1.37e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.37e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—INS—atherosclerosis	1.37e-06	1.43e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—atherosclerosis	1.36e-06	1.43e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.36e-06	1.43e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—atherosclerosis	1.35e-06	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.35e-06	1.41e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARA—atherosclerosis	1.34e-06	1.41e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—atherosclerosis	1.34e-06	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—atherosclerosis	1.31e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AGT—atherosclerosis	1.3e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—atherosclerosis	1.3e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK3—atherosclerosis	1.29e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—INS—atherosclerosis	1.29e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.28e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—atherosclerosis	1.28e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—atherosclerosis	1.28e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—INS—atherosclerosis	1.28e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAV1—atherosclerosis	1.26e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOA1—atherosclerosis	1.26e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.26e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—atherosclerosis	1.25e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—atherosclerosis	1.25e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOB—atherosclerosis	1.23e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NOS3—atherosclerosis	1.23e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NOS3—atherosclerosis	1.2e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.2e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—atherosclerosis	1.18e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LPL—atherosclerosis	1.18e-06	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—atherosclerosis	1.17e-06	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—atherosclerosis	1.16e-06	1.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.15e-06	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPX1—atherosclerosis	1.15e-06	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NOS3—atherosclerosis	1.13e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.12e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—atherosclerosis	1.12e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NOS3—atherosclerosis	1.12e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CD36—atherosclerosis	1.12e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—atherosclerosis	1.11e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—atherosclerosis	1.1e-06	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—INS—atherosclerosis	1.09e-06	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.06e-06	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARA—atherosclerosis	1.04e-06	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.03e-06	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.02e-06	1.07e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—atherosclerosis	1.02e-06	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—atherosclerosis	1.01e-06	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AGT—atherosclerosis	1.01e-06	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—atherosclerosis	1e-06	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—atherosclerosis	9.85e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAV1—atherosclerosis	9.76e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOA1—atherosclerosis	9.74e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NOS3—atherosclerosis	9.56e-07	1e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—atherosclerosis	9.43e-07	9.89e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—atherosclerosis	9.25e-07	9.7e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—atherosclerosis	8.89e-07	9.32e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—atherosclerosis	8.75e-07	9.17e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—atherosclerosis	8.7e-07	9.12e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—atherosclerosis	8.58e-07	9e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—INS—atherosclerosis	8.41e-07	8.82e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—atherosclerosis	7.71e-07	8.09e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—atherosclerosis	7.46e-07	7.83e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NOS3—atherosclerosis	7.38e-07	7.74e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—atherosclerosis	7.31e-07	7.67e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—atherosclerosis	7.3e-07	7.65e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—atherosclerosis	6.89e-07	7.23e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—atherosclerosis	6.75e-07	7.08e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—atherosclerosis	6.32e-07	6.63e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—atherosclerosis	5.64e-07	5.92e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—atherosclerosis	5.51e-07	5.77e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—atherosclerosis	5.19e-07	5.44e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—atherosclerosis	5.14e-07	5.39e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—atherosclerosis	4.4e-07	4.61e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—atherosclerosis	3.39e-07	3.56e-06	CbGpPWpGaD
